Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 220 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 8 results:
Author Title [ Type(Desc)] Year
Filters: Author is Hoes, A. W.  [Clear All Filters]
Journal Article
M. J. Warnier, Rutten, F. H., Souverein, P. C., de Boer, A., Hoes, A. W., and De Bruin, M. L., “Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol”, Pharmacoepidemiol Drug Saf, vol. 24, pp. 701-8, 2015.
J. Gho, Schmidt, A. F., Pasea, L., Koudstaal, S., Pujades-Rodriguez, M., Denaxas, S., Shah, A. D., Patel, R. S., Gale, C. P., Hoes, A. W., Cleland, J. G., Hemingway, H., and Asselbergs, F. W., “An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors”, BMJ Open, vol. 8, p. e018331, 2018.
R. G. Duijnhoven, Straus, S. M., Souverein, P. C., de Boer, A., Bosch, J. L., Hoes, A. W., and De Bruin, M. L., “Long-term use of 5alpha-reductase inhibitors and the risk of male breast cancer”, Cancer Causes Control, vol. 25, pp. 1577-82, 2014.
C. J. van den Dries, van Doorn, S., Souverein, P., Pajouheshnia, R., Moons, K. G. M., Hoes, A. W., Geersing, G. J., and van den Ham, H. A., “The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation”, TH Open, vol. 4, pp. e417-e426, 2020.
A. Uijl, Koudstaal, S., Direk, K., Denaxas, S., Groenwold, R. H. H., Banerjee, A., Hoes, A. W., Hemingway, H., and Asselbergs, F. W., “Risk factors for incident heart failure in age- and sex-specific strata: a population-based cohort using linked electronic health records”, Eur J Heart Fail, 2019.
E. M. van de Garde, Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M., and Leufkens, H. G., “Statin treatment and reduced risk of pneumonia in patients with diabetes”, Thorax, vol. 61, pp. 957-61, 2006.
A. Tran-Duy, Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., and de Boer, A., “Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study”, J Intern Med, vol. 285, pp. 205-214, 2019.
A. Tran-Duy, Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., and de Boer, A., “Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study”, J Intern Med, 2018.
[Page last reviewed 4 March 2021]